4.8 Article

Micro-ecology restoration of colonic inflammation by in-Situ oral delivery of antibody-laden hydrogel microcapsules

期刊

BIOACTIVE MATERIALS
卷 15, 期 -, 页码 305-315

出版社

KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2021.12.022

关键词

Antibody oral delivery; Hydrogel thin-shell microcapsules; Microfluidic; Gut microbiota; Colonic inflammation; Micro-ecology restoration

资金

  1. National Key Science and Technology Project of China [2018YFC2000500, 03]
  2. National Natural Science Foundation of China [81703430, 81803449]
  3. CAMS Innovation Fund for Medical Sciences [2019-I2M-5-045]
  4. Natural Science Foundation of Zhejiang Province [LYY20H300003]

向作者/读者索取更多资源

In-situ oral delivery of therapeutic antibodies is a convenient approach for chronic inflammation treatment. By using microcapsules as oral carriers, antibodies can survive in the gastrointestinal tract and achieve the same therapeutic effect as intravenous injection. The alteration of intestinal microorganism abundance after oral antibody-laden microcapsules delivery suggests the restoration of intestinal microecology.
In-situ oral delivery of therapeutic antibodies, like monoclonal antibody, for chronic inflammation treatment is the most convenient approach compared with other administration routes. Moreover, the abundant links between the gut microbiota and colonic inflammation indicate that the synergistic or antagonistic effect of gut microbiota to colonic inflammation. However, the antibody activity would be significantly affected while transferring through the gastrointestinal tract due to hostile conditions. Moreover, these antibodies have short serum half-lives, thus, require to be frequently administered with high doses to be effective, leading to low patient tolerance. Here, we develop a strategy utilizing thin shell hydrogel microcapsule fabricated by microfluidic technique as the oral delivering carrier. By encapsulating antibodies in these microcapsules, antibodies survive in the hostile gastrointestinal environment and rapidly release into the small intestine through oral administration mute, achieving the same therapeutic effect as the intravenous injection evaluated by a colonic inflammation disease model. Moreover, the abundance of some intestinal microorganisms as the indication of the improvement of inflammation has remarkably altered after in-situ antibody-laden microcapsules delivery, implying the restoration of micro-ecology of the intestine. These findings prove our microcapsules are exploited as an efficient oral delivery agent for antibodies with programmable function in clinical application.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据